Cas:1563-01-5 5-sulfo-4′-diethylamino-2,2′-dihydroxyazobenzene manufacturer & supplier

We serve Chemical Name:5-sulfo-4′-diethylamino-2,2′-dihydroxyazobenzene CAS:1563-01-5 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

5-sulfo-4'-diethylamino-2,2'-dihydroxyazobenzene

Chemical Name:5-sulfo-4′-diethylamino-2,2′-dihydroxyazobenzene
CAS.NO:1563-01-5
Synonyms:5-Sulfo-4′-diaethylamino-2′,2-dihydroxy-azobenzol;5-Sulfo-4′-diethylaMino-2,2′-dihydroxyazobenzene;DDB4′-Diethylamino-2,2′-dihydroxy-5-sulfoazobenzene;DDB;5-Sulfo-4′-diethylaMino-2,2′-dihydroxyazobenzene;3-(4-DIETHYLAMINO-2-HYDROXYPHENYLAZO)-4-HYDROXYBENZENESULFONIC ACID;4”-Diethylamino-2,2”-dihydroxyazobenzene-5-sulfonic acid;4′-Diethylamino-2,2′-dihydroxy-5-sulfoazobenzene;Sulfodiethylaminodihydroxyazobenzene
Molecular Formula:C16H19N3O5S
Molecular Weight:365.40400
HS Code:2927000090

Physical and Chemical Properties:
Melting point:N/A
Boiling point:205.5°C (rough estimate)
Density:1.38g/cm3
Index of Refraction:1.624
PSA:131.17000
Exact Mass:365.10500
LogP:4.68690

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like 5-Sulfo-4′-diaethylamino-2′,2-dihydroxy-azobenzol chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Sulfodiethylaminodihydroxyazobenzene physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,5-Sulfo-4′-diethylaMino-2,2′-dihydroxyazobenzene Use and application,5-Sulfo-4′-diethylaMino-2,2′-dihydroxyazobenzene technical grade,usp/ep/jp grade.


Related News: The U.S. Food & Drug Administration on Friday said Johnson & Johnson (JNJ.N) must throw away millions of doses of its COVID-19 vaccine that were manufactured at a problem-plagued Baltimore factory but also cleared millions for use. 5-sulfo-4′-diethylamino-2,2′-dihydroxyazobenzene manufacturer In recent years, with the increasing number of patent medicines whose patents have expired, the variety and quantity of generic drugs have also increased rapidly, which has brought huge market opportunities to the API market and the output of APIs has continued to increase. 5-sulfo-4′-diethylamino-2,2′-dihydroxyazobenzene supplier Dr. John K. Westwick, CEO of Resonant, added ��Resonant has created a platform for rapid generation of novel anti-tumor antibody candidates. 5-sulfo-4′-diethylamino-2,2′-dihydroxyazobenzene vendor Dr. John K. Westwick, CEO of Resonant, added ��Resonant has created a platform for rapid generation of novel anti-tumor antibody candidates. 5-sulfo-4′-diethylamino-2,2′-dihydroxyazobenzene factory The monthly injection to suppress the virus that causes AIDS was aimed as an alternative to daily pills.